<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-05-12T10:42:29Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/ojh.000006">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/ojh.000006</identifier>
									<datestamp>2021-03-10</datestamp>
									<setSpec>PTZ.OJH:VOL3</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Do we really need nutraceutical liver support? Experimental effectiveness, risks and proven clinical benefits
										</dc:title><dc:creator>Francesco Marotta</dc:creator><dc:creator> Aldo Lorenzetti</dc:creator><dc:creator> Saida Rasulova</dc:creator><dc:creator> Baskar Balakrishnan</dc:creator><dc:creator> Anna Cabeca</dc:creator><dc:creator>Fang HE</dc:creator><dc:description>&lt;p&gt;Liver is the largest and one of the most metabolically active organ in the body. With a crucial role in the clearance of toxins such as aflatoxins, microbes and metabolic by-products. This constant exposure to inner and environmental harmful substances may be potentially overwhelmed and be affected by a degree of liver damage ranging from hepatitis and Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcohol Steatohepatitis (NASH), These latter two with worrying worldwide expansion (Figure 1) up to liver cirrhosis and hepatocellular carcinoma while representing a risk factor for other illnesss such as cardiovascular disease, stroke and diabetes.&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;br&gt;&lt;/p&gt;</dc:description>
										<dc:publisher>Open Journal of Hepatology - Peertechz Publications</dc:publisher>
										<dc:date>2021-03-10</dc:date>
										<dc:type>Short Communication</dc:type>
										<dc:identifier>https://doi.org/10.17352/ojh.000006</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Francesco Marotta et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
